Cramer’s Favorite 2019 IPO’s, Emergent BioSolutions CEO, ThoughtSpot CEO

Mad Money w/ Jim Cramer

CNBC

News, Investing, Business

4.3 • 4K Ratings

🗓️ 20 December 2019

⏱️ 45 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

The Dow skyrocketed 138 points today and Jim Cramer’s breaking down today’s rally, with the Dow, S&P, and Nasdaq breaking all-time highs. Then, it was the year of the IPO, but which one’s deserve Cramer’s praise now that we’re heading into 2020? And, CEO of Emergent BioSolutions Robert Kramer sits down with Cramer to talk about the company’s growth, new acquisitions, and a 40% rally from its lows in August. Plus, Sudheesh Nair, CEO of ThoughtSpot, discusses where what the private start-up’s mission could mean for the data analytics industry.

Transcript

Click on a timestamp to play from that location

0:00.0	My mission is simple to make you money.
0:05.0	I'm here to level the playing field for all investors.
0:08.0	There's always a more market summer,
0:10.0	and I promised to help you find it.
0:12.0	Man money starts now!
0:16.0	K-On Cramer!
0:17.0	Welcome to Man of Money. Welcome to Cramer America.
0:19.0	I'll be one of my friends. I'm just trying to make you some money.
0:22.0	My job is not to set a table for the edge-game teachers.
0:24.0	Call me 1-800-743-CBC.
0:27.0	Or Twitty.
0:28.0	At Jim Cramer.
0:30.0	Read-throughs.
0:32.0	So much of successful investing is about read-throughs.
0:35.0	Dissecting the less obvious pin action
0:40.0	when a company reports earnings.
0:44.0	After a strong day, down-gain 138 points,
0:47.0	this can be advanced.45% now. That's not a climb.67%.
0:50.0	You know what?
0:51.0	I want to go over the best read-throughs in the session.
0:53.0	Why don't we start with the commentary
0:55.0	surrounding the excellent quarter from Mike Ron.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.